Our study provides a comprehensive analysis into how APOE genotype influences the trajectory of AD-tau and AGD-tau pathologies by incorporating biochemical measures, thus supplementing, and enriching our understanding of the neuropathological studies previously published. This evidence concerns the gene MAPT and argyrophilic grain disease.